The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children
Open accessAbstract
BACKGROUND: Universal vaccination of children 6 to 59 months of age with trivalent inactivated influenza vaccine has recently been recommended by U.S. advisory bodies. To evaluate alternative vaccine approaches, we compared the safety and efficacy of intranasally administered live attenuated influenza vaccine with those of inactivated vaccine in infants and young children. METHODS: Children 6 to 59 months of age, without a recent episode of wheezing illness or severe asthma, were randomly assigned in a 1:1 ratio to receive either cold-adapted trivalent live attenuated influenza vaccine (a refrigeration-stable formulation of live attenuated intranasally administered influenza vaccine) or trivalent inactivated vaccine in a double-blind manner. Influenza-like illness was monitored with cultures throughout the 2004-2005 influenza season. RESULTS: Safety data were available for 8352 children, and 7852 children completed the study according to the protocol. There were 54.9% fewer cases of cultured-confirmed influenza in the group that received live attenuated vaccine than in the group that received inactivated vaccine (153 vs. 338 cases, P<0.001). The superior efficacy of live attenuated vaccine, as compared with inactivated vaccine, was observed for both antigenically well-matched and drifted viruses. Among previously unvaccinated children, wheezing within 42 days after the administration of dose 1 was more common with live attenuated vaccine than with inactivated vaccine, primarily among children 6 to 11 months of age; in this age group, 12 more episodes of wheezing were noted within 42 days after receipt of dose 1 among recipients of live attenuated vaccine (3.8%) than among recipients of inactivated vaccine (2.1%, P=0.076). Rates of hospitalization for any cause during the 180 days after vaccination were higher among the recipients of live attenuated vaccine who were 6 to 11 months of age (6.1%) than among the recipients of inactivated vaccine in this age group (2.6%, P=0.002). CONCLUSIONS: Among young children, live attenuated vaccine had significantly better efficacy than inactivated vaccine. An evaluation of the risks and benefits indicates that live attenuated vaccine should be a highly effective, safe vaccine for children 12 to 59 months of age who do not have a history of asthma or wheezing. (ClinicalTrials.gov number, NCT00128167 [ClinicalTrials.gov].).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,011
Belshe, R. B., Mendelman, P. M., Treanor, J., King, J., Gruber, W. C., Piedra, P., Bernstein, D. I., Hayden, F. G., Kotloff, K., Zangwill, K., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805143382002 · Cited by 916
Self-citationThe Underrecognized Burden of Influenza in Young Children
Poehling, K. A., Edwards, K. M., Weinberg, G. A., Szilagyi, P., Staat, M. A., Iwane, M. K., Bridges, C. B., Grijalva, C. G., Zhu, Y., Bernstein, D. I., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054869 · Cited by 872
Self-citationThe Japanese Experience with Vaccinating Schoolchildren against Influenza
Reichert, T. A., Sugaya, N., Fedson, D. S., Glezen, W. P., Simonsen, L., & Tashiro, M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103223441204 · Cited by 861
Belshe, R. B., Gruber, W. C., Mendelman, P. M., Cho, I., Reisinger, K., Block, S. L., Wittes, J., Iacuzio, D., Piedra, P., Treanor, J., et al. (2000) · The Journal of Pediatrics · doi:10.1016/s0022-3476(00)70097-7 · Cited by 431
Self-citationAshkenazi, S., Vertruyen, A., Ar??stegui, J., Esposito, S., McKeith, D. D., Klemola, T., Biolek, J., K??hr, J., Bujnowski, T., Desgrandchamps, D., et al. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000237829.66310.85 · Cited by 313
Fleming, D. M., Crovari, P., Wahn, U., Klemola, T., Schlesinger, Y., Langussis, A., ??ymar, K., Garcia, M. L., Krygier, A., Costa, H., et al. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000237797.14283.cf · Cited by 272
Strategy for Distribution of Influenza Vaccine to High-Risk Groups and Children
Longini, I. M. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi053 · Cited by 205
BERGEN, R., BLACK, S., SHINEFIELD, H., LEWIS, E., RAY, P., HANSEN, J., WALKER, R., HESSEL, C., CORDOVA, J., & MENDELMAN, P. M. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000109392.96411.4f · Cited by 167
Self-citationSafety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine
Belshe, R. B., Lee, M., WALKER, R. E., Stoddard, J. J., & Mendelman, P. M. (2004) · Expert Review of Vaccines · doi:10.1586/14760584.3.6.643 · Cited by 131
Self-citation
Cited by
Bradley, J. S., Byington, C. L., Shah, S. S., Alverson, B., Carter, E. R., Harrison, C., Kaplan, S. L., Mace, S. E., McCracken, G. H., Moore, M. R., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir531 · Cited by 1,919
Grohskopf, L. A., Sokolow, L. Z., Broder, K. R., Walter, E. B., Fry, A. M., & Jernigan, D. B. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6703a1 · Cited by 1,632
Emergence and pandemic potential of swine-origin H1N1 influenza virus
Neumann, G., Noda, T., & Kawaoka, Y. (2009) · Nature · doi:10.1038/nature08157 · Cited by 1,561
The Diagnosis and Management of Acute Otitis Media
Lieberthal, A. S., Carroll, A. E., Chonmaitree, T., Ganiats, T. G., Hoberman, A., Jackson, M. A., Joffe, M. D., Miller, D. T., Rosenfeld, R. M., Sevilla, X. D., et al. (2013) · Pediatrics · doi:10.1542/peds.2012-3488 · Cited by 1,442
Evidence for Health Decision Making — Beyond Randomized, Controlled Trials
Frieden, T. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1614394 · Cited by 770
Influenza vaccine: The challenge of antigenic drift
CARRAT, F., & FLAHAULT, A. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.07.027 · Cited by 708
Grohskopf, L. A., Sokolow, L. Z., Broder, K. R., Olsen, S. J., Karron, R. A., Jernigan, D. B., & Bresee, J. S. (2016) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6505a1 · Cited by 593
Schilder, A. G. M., Chonmaitree, T., Cripps, A. W., Rosenfeld, R. M., Casselbrant, M. L., Haggard, M. P., & Venekamp, R. P. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.63 · Cited by 577
Nasal drug delivery devices: characteristics and performance in a clinical perspective—a review
Djupesland, P. G. (2013) · Drug Delivery and Translational Research · doi:10.1007/s13346-012-0108-9 · Cited by 563
Zens, K. D., Chen, J. K., & Farber, D. L. (2016) · JCI Insight · doi:10.1172/jci.insight.85832 · Cited by 418
COVID-19 vaccines: The status and perspectives in delivery points of view
Chung, J. Y., Thone, M. N., & Kwon, Y. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.011 · Cited by 375
A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants
Zhu, Q., McLellan, J. S., Kallewaard, N. L., Ulbrandt, N. D., Palaszynski, S., Zhang, J., Moldt, B., Khan, A., Svabek, C., McAuliffe, J. M., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaj1928 · Cited by 362
Oil-in-Water Emulsion Adjuvant with Influenza Vaccine in Young Children
Vesikari, T., Knuf, M., Wutzler, P., Karvonen, A., Kieninger-Baum, D., Schmitt, H.-J., Baehner, F., Borkowski, A., Tsai, T. F., & Clemens, R. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010331 · Cited by 317
Self-citationThe History of Therapeutic Aerosols: A Chronological Review
Stein, S. W., & Thiel, C. G. (2017) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2016.1297 · Cited by 309
Influenza Hemagglutination-Inhibition Antibody Titer as a Correlate of Vaccine-Induced Protection
Ohmit, S. E., Petrie, J. G., Cross, R. T., Johnson, E., & Monto, A. S. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir661 · Cited by 296
Influenza Vaccine Effectiveness in the United States during the 2015–2016 Season
Jackson, M. L., Chung, J. R., Jackson, L. A., Phillips, C. H., Benoit, J., Monto, A. S., Martin, E. T., Belongia, E. A., McLean, H. Q., Gaglani, M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1700153 · Cited by 283
Grohskopf, L. A., Sokolow, L. Z., Olsen, S. J., Bresee, J. S., Broder, K. R., & Karron, R. A. (2015) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6430a3 · Cited by 273
Grohskopf, L. A., Olsen, S. J., Sokolow, L. Z., Bresee, J. S., Cox, N. J., Broder, K. R., Karron, R. A., & Walter, E. B. (2014) · American Journal of Transplantation · doi:10.1111/ajt.13065 · Cited by 262
Treanor, J. J., Talbot, H. K., Ohmit, S. E., Coleman, L. A., Thompson, M. G., Cheng, P.-Y., Petrie, J. G., Lofthus, G., Meece, J. K., Williams, J. V., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis574 · Cited by 258
Plotkin, S. A. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00290-09 · Cited by 256
Forrest, B. D., Pride, M. W., Dunning, A. J., Capeding, M. R. Z., Chotpitayasunondh, T., Tam, J. S., Rappaport, R., Eldridge, J. H., & Gruber, W. C. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00397-07 · Cited by 256
Carter, N. J., & Curran, M. P. (2011) · Drugs · doi:10.2165/11206860-000000000-00000 · Cited by 252
Yang, C., Skiena, S., Futcher, B., Mueller, S., & Wimmer, E. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307473110 · Cited by 103
Mina, M. J., McCullers, J. A., & Klugman, K. P. (2014) · mBio · doi:10.1128/mbio.01040-13 · Cited by 91
Thors, V., Christensen, H., Morales-Aza, B., Vipond, I., Muir, P., & Finn, A. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201510-2000oc · Cited by 44
Metadata
- Authors
- Belshe, R. B., Edwards, K. M., Vesikari, T., Black, S. V., Walker, R. E., Hultquist, M., Kemble, G., & Connor, E. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-02-15
- Volume
- 356
- Issue
- 7
- Pages
- 685-696
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2102847984
- Cited by
- 811
- References
- 14
- FWCI
- 42.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.